IDEX Corp (IEX) stock

IEXNYSEPumps & Pumping EquipmentFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3031% above fair value

$233.84−5.49 (-2.29%)

Close on Oct 30, 2026Market cap $17.24BP/E 33.6Yield 1.21%

Earnings

IDEX's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 3, 2027

Q4 FY2026 · estimated, before the open

Revenue, Q3 FY2026

$952.00M

+8.3% on a year earlier

adjusted diluted EPS, Q3 FY2026

$2.33

$2.03 a year earlier

Latest guidance

Issued

Oct 28, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of IDEX's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 31, 2026	Feb 3, 2027Expected	–	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Oct 28, 2026before the open	$952.00M	+8.3%	$1.95	$2.33	Release
Q2 FY2026ended Jun 30, 2026	Jul 29, 2026before the open	$921.00M	+6.5%	$1.93	$2.32	Release
Q1 FY2026ended Mar 31, 2026	Apr 29, 2026before the open	$887.00M	+9.0%	$1.61	$2.00	Release
Q4 FY2025ended Dec 31, 2025	Feb 4, 2026before the open	$899.00M	+4.2%	$1.71	$2.10	Release
Q3 FY2025ended Sep 30, 2025	Oct 29, 2025before the open	$879.00M	+10.2%	$1.70	$2.03	Release
Q2 FY2025ended Jun 30, 2025	Jul 30, 2025before the open	$865.00M	+7.2%	$1.74	$2.07	Release
Q1 FY2025ended Mar 31, 2025	May 1, 2025before the open	$814.00M	+1.6%	$1.26	$1.75	Release
Q4 FY2024ended Dec 31, 2024	Feb 4, 2025during market hours	$863.00M	+9.4%	$1.62	$2.04	Release
Q3 FY2024ended Sep 30, 2024	Oct 30, 2024before the open	$798.00M	+0.6%	$1.57	$1.90	Release
Q2 FY2024ended Jun 30, 2024	Aug 1, 2024before the open	$807.00M	-4.6%	$1.86	$2.06	Release
Q1 FY2024ended Mar 31, 2024	Apr 24, 2024before the open	$801.00M	-5.3%	$1.60	$1.88	Release
Q4 FY2023ended Dec 31, 2023	Feb 7, 2024before the open	$788.90M	-2.7%	$1.43	$1.83	Release
Q3 FY2023ended Sep 30, 2023	Oct 26, 2023before the open	$793.40M	-3.7%	$2.75	$2.12	Release
Q2 FY2023ended Jun 30, 2023	Jul 27, 2023before the open	$846.20M	+6.3%	$1.82	$2.18	Release
Q1 FY2023ended Mar 31, 2023	Apr 27, 2023before the open	$845.40M	+12.6%	$1.84	$2.09	Release
Q4 FY2022ended Dec 31, 2022	Feb 1, 2023before the open	$810.70M	+13.4%	$1.71	$2.01	Release
Q3 FY2022ended Sep 30, 2022	Oct 26, 2022before the open	$824.00M	+15.7%	$2.36	$2.14	Release
Q2 FY2022ended Jun 30, 2022	Jul 27, 2022before the open	$796.10M	–	$1.81	$2.02	Release
Q1 FY2022ended Mar 31, 2022	Apr 27, 2022before the open	$751.10M	–	$1.83	$1.96	Release
Q4 FY2021ended Dec 31, 2021	Feb 2, 2022before the open	$714.80M	–	$1.55	$1.55	Release
Q3 FY2021ended Sep 30, 2021	Oct 27, 2021before the open	$712.00M	–	$1.51	$1.63	Release
Q2 FY2021ended Jun 30, 2021	Jul 28, 2021before the open	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	Apr 28, 2021before the open	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 4, 2021before the open	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Oct 28, 2020before the open	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

IDEX's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
organic salesnon-GAAP	FY2026	+6.5% – +6.8%	–	New	Oct 28, 2026
organic salesnon-GAAP	FY2026	+1% – +2%	–	New	Feb 4, 2026
organic salesnon-GAAP	FY2026	+5% – +6%	+3% – +4%	Raised	Jul 29, 2026
adjusted diluted EPSnon-GAAP	FY2026	$8.91 – $8.96	–	New	Oct 28, 2026
adjusted diluted EPSnon-GAAP	FY2026	$8.70 – $8.85	$8.35 – $8.55	Raised	Jul 29, 2026

Guidance vs results

The last range IDEX gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
Q3 FY2026	adjusted diluted EPS	$2.20 – $2.25	$2.33	Above range
Q2 FY2026	adjusted diluted EPS	$2.07 – $2.12	$2.32	Above range
Q1 FY2026	adjusted diluted EPS	$1.73 – $1.78	$2.00	Above range
FY2025	adjusted diluted EPS	$7.86 – $7.91	$7.95Σ4Q	Above range
FY2025	EPS (GAAP)	$6.35 – $6.40	$6.41Σ4Q	Above range
FY2025	Revenue	$3.45B – $3.46B	$3.46BΣ4Q	Within range
FY2025	Revenue growth	+5% – +6%	+5.75%Σ4Q	Within range
Q3 FY2025	adjusted diluted EPS	$1.90 – $1.95	$2.03	Above range
Q3 FY2025	EPS (GAAP)	$1.54 – $1.61	$1.70	Above range
Q3 FY2025	Revenue	$853.80M – $867.80M	$879.00M	Above range
Q3 FY2025	Revenue growth	+7% – +9%	+10.15%	Above range
Q2 FY2025	adjusted diluted EPS	$1.95 – $2.05	$2.07	Above range
Q2 FY2025	EPS (GAAP)	$1.60 – $1.72	$1.74	Above range
Q2 FY2025	Revenue	$854.30M – $870.40M	$865.00M	Within range
Q2 FY2025	Revenue growth	+6% – +8%	+7.19%	Within range
Q1 FY2025	adjusted diluted EPS	$1.60 – $1.65	$1.75	Above range
Q1 FY2025	EPS (GAAP)	$1.18 – $1.24	$1.26	Above range
Q4 FY2024	EPS (GAAP)	$1.64 – $1.69	$1.62	Below range
Q4 FY2024	Estimated adjusted diluted EPS attributable to IDEX	$2.01 – $2.06	$2.04	Within range
Q4 FY2024	Revenue	$874.30M – $882.30M	$863.00M	Below range
Q4 FY2024	Revenue growth	+10% – +11%	+9.39%	Below range
Q3 FY2024	adjusted diluted EPS	$1.85 – $1.90	$1.90	Within range
Q3 FY2024	EPS (GAAP)	$1.61 – $1.66	$1.57	Below range
Q2 FY2024	adjusted diluted EPS	$2.00 – $2.05	$2.06	Above range
Q2 FY2024	EPS (GAAP)	$1.75 – $1.80	$1.86	Above range
Q1 FY2024	adjusted diluted EPS	$1.70 – $1.75	$1.88	Above range
Q1 FY2024	EPS (GAAP)	$1.45 – $1.50	$1.60	Above range
Q4 FY2023	adjusted diluted EPS	$1.74 – $1.79	$1.83	Above range
Q4 FY2023	EPS (GAAP)	$1.50 – $1.55	$1.43	Below range
Q3 FY2023	adjusted EPS	$1.84 – $1.89	$2.12	Above range
Q3 FY2023	EPS (GAAP)	$1.60 – $1.65	$2.75	Above range
Q2 FY2023	adjusted EPS	$2.10 – $2.13	$2.18	Above range
Q2 FY2023	EPS (GAAP)	$1.86 – $1.89	$1.82	Below range
Q1 FY2023	adjusted EPS	$1.98 – $2.03	$2.09	Above range
Q1 FY2023	EPS (GAAP)	$1.74 – $1.79	$1.84	Above range
Q4 FY2022	adjusted EPS attributable to IDEX	$1.92 – $1.97	$2.01	Above range
Q4 FY2022	EPS (GAAP)	$1.75 – $1.80	$1.71	Below range
Q3 FY2022	adjusted EPS attributable to IDEX	$1.98 – $2.03	$2.14	Above range
Q3 FY2022	EPS (GAAP)	$1.80 – $1.85	$2.36	Above range
Q2 FY2022	adjusted EPS attributable to IDEX	$1.85 – $1.90	$2.02	Above range
Q2 FY2022	EPS (GAAP)	$1.69 – $1.74	$1.81	Above range
Q1 FY2022	adjusted EPS	$1.73 – $1.76	$1.96	Above range
Q1 FY2022	EPS (GAAP)	$1.57 – $1.60	$1.83	Above range
Q4 FY2021	EPS	$1.55 – $1.58	$1.55	Within range

Guidance history

Every forecast IDEX put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Oct 28, 2026	adjusted diluted EPS	FY2026	$8.91 – $8.96	New
Oct 28, 2026	organic sales	FY2026	+6.5% – +6.8%	New
Jul 29, 2026	organic sales	Q3 FY2026	+5% – +7%	New
Jul 29, 2026	organic sales	FY2026	+5% – +6%	Raised
Jul 29, 2026	adjusted diluted EPS	Q3 FY2026	$2.20 – $2.25	New
Jul 29, 2026	adjusted diluted EPS	FY2026	$8.70 – $8.85	Raised
Apr 29, 2026	organic sales	FY2026	+3% – +4%	New
Apr 29, 2026	organic sales	Q2 FY2026	+3% – +4%	New
Apr 29, 2026	adjusted diluted EPS	FY2026	$8.35 – $8.55	Raised
Apr 29, 2026	adjusted diluted EPS	Q2 FY2026	$2.07 – $2.12	New
Feb 4, 2026	adjusted diluted EPS	FY2026	$8.15 – $8.35	New
Feb 4, 2026	adjusted diluted EPS	Q1 FY2026	$1.73 – $1.78	New
Feb 4, 2026	organic sales	FY2026	+1% – +2%	New
Feb 4, 2026	organic sales	Q1 FY2026	+1%	New
Oct 29, 2025	Adjusted EBITDA	FY2025	$921.20M – $926.10M	Narrowed
Oct 29, 2025	adjusted diluted EPS	FY2025	$7.86 – $7.91	Narrowed
Oct 29, 2025	GAAP diluted EPS	FY2025	$6.35 – $6.40	Narrowed
Oct 29, 2025	Net income margin	FY2025	13.9%	Lowered
Oct 29, 2025	Adjusted EBITDA margin	FY2025	26.5% – 27%	Reaffirmed
Oct 29, 2025	Reported net income	FY2025	$478.00M – $481.60M	Narrowed
Oct 29, 2025	change in net sales	FY2025	+5% – +6%	Reaffirmed
Oct 29, 2025	organic sales growth	FY2025	+1%	New
Oct 29, 2025	Net sales	FY2025	$3.45B – $3.46B	Raised
Jul 30, 2025	organic sales growth	FY2025	+1%	New
Jul 30, 2025	organic sales growth	Q3 FY2025	+2% – +3%	New
Jul 30, 2025	Estimated Adjusted EBITDA	FY2025	$918.00M – $928.50M	New
Jul 30, 2025	Estimated Adjusted EBITDA	Q3 FY2025	$225.90M – $231.40M	New
Jul 30, 2025	adjusted diluted EPS	FY2025	$7.85 – $7.95	New
Jul 30, 2025	adjusted diluted EPS	Q3 FY2025	$1.90 – $1.95	New
Jul 30, 2025	GAAP diluted EPS	FY2025	$6.30 – $6.44	New
Jul 30, 2025	GAAP diluted EPS	Q3 FY2025	$1.54 – $1.61	New
Jul 30, 2025	Estimated Net income margin	FY2025	13.9% – 14.1%	New
Jul 30, 2025	Estimated Adjusted EBITDA margin	FY2025	26.5% – 27%	New
Jul 30, 2025	Estimated Reported net income	FY2025	$476.20M – $487.20M	New
Jul 30, 2025	Estimated Net income margin	Q3 FY2025	13.6% – 14%	New
Jul 30, 2025	Estimated Adjusted EBITDA margin	Q3 FY2025	26% – 26.5%	New
Jul 30, 2025	Estimated Reported net income	Q3 FY2025	$116.20M – $121.80M	New
Jul 30, 2025	Estimated change in net sales	FY2025	+5% – +6%	New
Jul 30, 2025	Estimated Net sales	FY2025	$3.43B – $3.46B	New
Jul 30, 2025	Estimated change in net sales	Q3 FY2025	+7% – +9%	New
Jul 30, 2025	Estimated Net sales	Q3 FY2025	$853.80M – $867.80M	New
May 1, 2025	Estimated Adjusted EBITDA	FY2025	$939.80M – $973.20M	New
May 1, 2025	Estimated Adjusted EBITDA	Q2 FY2025	$226.80M – $236.10M	New
May 1, 2025	adjusted diluted EPS	Q2 FY2025	$1.95 – $2.05	New
May 1, 2025	adjusted diluted EPS	FY2025	$8.10 – $8.45	Reaffirmed
May 1, 2025	GAAP diluted EPS	Q2 FY2025	$1.60 – $1.72	New
May 1, 2025	GAAP diluted EPS	FY2025	$6.56 – $6.95	Lowered
May 1, 2025	Estimated Net income margin	Q2 FY2025	14.2% – 14.9%	New
May 1, 2025	Estimated Adjusted EBITDA margin	Q2 FY2025	26.5% – 27%	New
May 1, 2025	organic sales growth	Q2 FY2025	0% – +2%	New
May 1, 2025	Estimated Net income margin	FY2025	14.6% – 15.2%	New
May 1, 2025	Estimated Adjusted EBITDA margin	FY2025	27.5% – 28%	New
May 1, 2025	organic sales growth	FY2025	+1% – +3%	New
May 1, 2025	Estimated change in net sales	Q2 FY2025	+6% – +8%	New
May 1, 2025	Estimated Net sales	Q2 FY2025	$854.30M – $870.40M	New
May 1, 2025	Estimated change in net sales	FY2025	+4% – +6%	New
May 1, 2025	Estimated Net sales	FY2025	$3.42B – $3.48B	New
Feb 4, 2025	adjusted diluted EPS	FY2025	$8.10 – $8.45	New
Feb 4, 2025	adjusted diluted EPS	Q1 FY2025	$1.60 – $1.65	New
Feb 4, 2025	GAAP diluted EPS	FY2025	$6.56 – $6.96	New
Feb 4, 2025	GAAP diluted EPS	Q1 FY2025	$1.18 – $1.24	New
Feb 4, 2025	organic sales	Q1 FY2025	-4% – -3%	New
Feb 4, 2025	organic sales	FY2025	+1% – +3%	New
Oct 30, 2024	Estimated Adjusted EBITDA	Q4 FY2024	$235.80M – $241.50M	New
Oct 30, 2024	Estimated adjusted diluted EPS attributable to IDEX	Q4 FY2024	$2.01 – $2.06	New
Oct 30, 2024	Adjusted diluted EPS	FY2024	$7.85 – $7.90	Raised
Oct 30, 2024	GAAP diluted EPS	FY2024	$6.65 – $6.70	Lowered
Oct 30, 2024	Estimated diluted EPS attributable to IDEX	Q4 FY2024	$1.64 – $1.69	New
Oct 30, 2024	Estimated Reported net income	Q4 FY2024	$123.10M – $127.40M	New
Oct 30, 2024	Estimated Adjusted EBITDA margin	Q4 FY2024	27% – 27.4%	New
Oct 30, 2024	Estimated Net income margin	Q4 FY2024	14.1% – 14.4%	New
Oct 30, 2024	organic sales growth	FY2024	-2% – -1%	Reaffirmed
Oct 30, 2024	Change in organic net sales	Q4 FY2024	+3% – +4%	New
Oct 30, 2024	Change in net sales	Q4 FY2024	+10% – +11%	New
Oct 30, 2024	Estimated Net sales	Q4 FY2024	$874.30M – $882.30M	New
Aug 1, 2024	adjusted diluted EPS	Q3 FY2024	$1.85 – $1.90	New
Aug 1, 2024	adjusted diluted EPS	FY2024	$7.80 – $7.90	Lowered
Aug 1, 2024	GAAP diluted EPS	Q3 FY2024	$1.61 – $1.66	New
Aug 1, 2024	GAAP diluted EPS	FY2024	$6.85 – $6.95	Lowered
Aug 1, 2024	organic sales	Q3 FY2024	0% – +1%	New
Aug 1, 2024	organic sales growth	FY2024	-2% – -1%	Lowered
Apr 24, 2024	adjusted diluted EPS	Q2 FY2024	$2.00 – $2.05	New
Apr 24, 2024	adjusted diluted EPS	FY2024	$8.15 – $8.45	Reaffirmed
Apr 24, 2024	GAAP diluted EPS	Q2 FY2024	$1.75 – $1.80	New
Apr 24, 2024	GAAP diluted EPS	FY2024	$7.13 – $7.43	Lowered
Apr 24, 2024	organic sales	Q2 FY2024	-3% – -2%	New
Apr 24, 2024	organic sales growth	FY2024	0% – +2%	Reaffirmed
Feb 7, 2024	adjusted diluted EPS	Q1 FY2024	$1.70 – $1.75	New
Feb 7, 2024	adjusted diluted EPS	FY2024	$8.15 – $8.45	New
Feb 7, 2024	GAAP diluted EPS	Q1 FY2024	$1.45 – $1.50	New
Feb 7, 2024	GAAP diluted EPS	FY2024	$7.15 – $7.45	New
Feb 7, 2024	organic sales	Q1 FY2024	-7% – -6%	New
Feb 7, 2024	organic sales growth	FY2024	0% – +2%	New
Oct 26, 2023	adjusted diluted EPS	Q4 FY2023	$1.74 – $1.79	New
Oct 26, 2023	adjusted diluted EPS	FY2023	$8.13 – $8.18	Raised
Oct 26, 2023	GAAP diluted EPS	Q4 FY2023	$1.50 – $1.55	New
Oct 26, 2023	GAAP diluted EPS	FY2023	$7.91 – $7.96	Raised
Oct 26, 2023	organic sales	Q4 FY2023	-9% – -8%	New
Oct 26, 2023	organic sales	FY2023	-2% – -1%	Reaffirmed
Jul 27, 2023	adjusted EPS	Q3 FY2023	$1.84 – $1.89	New
Jul 27, 2023	adjusted EPS	FY2023	$7.90 – $8.00	Lowered
Jul 27, 2023	GAAP EPS	Q3 FY2023	$1.60 – $1.65	New
Jul 27, 2023	GAAP EPS	FY2023	$6.80 – $6.90	Lowered
Jul 27, 2023	organic sales	Q3 FY2023	-8% – -7%	New
Jul 27, 2023	organic sales	FY2023	-2% – -1%	Lowered
Apr 27, 2023	adjusted EPS	Q2 FY2023	$2.10 – $2.13	New
Apr 27, 2023	adjusted EPS	FY2023	$8.25 – $8.55	Lowered
Apr 27, 2023	GAAP EPS	Q2 FY2023	$1.86 – $1.89	New
Apr 27, 2023	GAAP EPS	FY2023	$7.30 – $7.60	Lowered
Apr 27, 2023	organic sales growth	Q2 FY2023	+3%	New
Apr 27, 2023	organic sales growth	FY2023	0% – +3%	Lowered
Feb 1, 2023	adjusted EPS	Q1 FY2023	$1.98 – $2.03	New
Feb 1, 2023	adjusted EPS	FY2023	$8.50 – $8.80	New
Feb 1, 2023	GAAP EPS	Q1 FY2023	$1.74 – $1.79	New
Feb 1, 2023	GAAP EPS	FY2023	$7.55 – $7.85	New
Feb 1, 2023	organic sales growth	Q1 FY2023	+3% – +5%	New
Feb 1, 2023	organic sales growth	FY2023	+1% – +5%	New
Oct 26, 2022	adjusted EPS attributable to IDEX	Q4 FY2022	$1.92 – $1.97	New
Oct 26, 2022	adjusted EPS attributable to IDEX	FY2022	$8.04 – $8.09	Raised
Oct 26, 2022	reported EPS attributable to IDEX	Q4 FY2022	$1.75 – $1.80	New
Oct 26, 2022	reported EPS attributable to IDEX	FY2022	$7.75 – $7.80	Raised
Oct 26, 2022	organic sales increase	Q4 FY2022	+9%	New
Oct 26, 2022	organic sales growth	FY2022	+12%	Raised
Jul 27, 2022	adjusted EPS attributable to IDEX	Q3 FY2022	$1.98 – $2.03	New
Jul 27, 2022	adjusted EPS attributable to IDEX	FY2022	$7.88 – $7.98	Raised
Jul 27, 2022	reported EPS attributable to IDEX	Q3 FY2022	$1.80 – $1.85	New
Jul 27, 2022	reported EPS attributable to IDEX	FY2022	$7.19 – $7.29	Raised
Jul 27, 2022	organic sales increase	Q3 FY2022	+9% – +10%	New
Jul 27, 2022	organic sales growth	FY2022	+10%	Raised
Apr 27, 2022	adjusted EPS attributable to IDEX	Q2 FY2022	$1.85 – $1.90	New
Apr 27, 2022	adjusted EPS attributable to IDEX	FY2022	$7.50 – $7.63	Raised
Apr 27, 2022	reported EPS attributable to IDEX	Q2 FY2022	$1.69 – $1.74	New
Apr 27, 2022	reported EPS attributable to IDEX	FY2022	$6.87 – $7.00	Raised
Apr 27, 2022	organic sales increase	Q2 FY2022	+8% – +9%	New
Apr 27, 2022	organic sales growth	FY2022	+6% – +8%	Raised
Feb 2, 2022	adjusted EPS	Q1 FY2022	$1.73 – $1.76	New
Feb 2, 2022	adjusted EPS	FY2022	$7.33 – $7.63	New
Feb 2, 2022	GAAP EPS	Q1 FY2022	$1.57 – $1.60	New
Feb 2, 2022	GAAP EPS	FY2022	$6.70 – $7.00	New
Feb 2, 2022	organic sales increase	Q1 FY2022	+6% – +7%	New
Feb 2, 2022	Organic sales growth	FY2022	+5% – +8%	New
Oct 27, 2021	EPS	Q4 FY2021	$1.55 – $1.58	New
Oct 27, 2021	adjusted EPS	FY2021	$6.30 – $6.33	New
Oct 27, 2021	organic sales growth	Q4 FY2021	+9% – +10%	New
Oct 27, 2021	organic sales growth	FY2021	+11% – +12%	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.